Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in EOLS — Evolus, Inc.

CIK 1167557 Greenwich, CT
Back to EOLS Full portfolio

Position in EOLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$677,085
+$571,555 QoQ
Shares Held
97,563
+280.0% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 158 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. EOLS ranks #37 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 3,818,037 $643,491,951
2 UTHR
UNITED THERAPEUTICS Corp
 546,002 $295,840,259
3 ZTS
Zoetis Inc.
 1,070,929 $76,956,955
4 VTRS
Viatris Inc
 4,694,966 $74,556,056
5 PRGO
PERRIGO Co plc
 3,480,666 $36,164,117
6 LNTH
Lantheus Holdings, Inc.
 261,250 $28,983,071
7 IRWD
Ironwood Pharmaceuticals Inc
 6,465,921 $27,221,524
8 TAK
Takeda Pharmaceutical Co Ltd
 1,525,686 $24,456,745

All Filings in EOLS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $677,085 97,563
2026-03-31 $105,530 25,677
2025-12-31 $152,796 22,977
2025-09-30 $358,226 58,343
2025-06-30 $656,349 71,265
2025-03-31 $802,856 66,738
2024-12-31 $1,733,765 157,044
2024-09-30 $2,422,903 149,562
2024-06-30 $781,275 72,007
2024-03-31 $756,504 54,036
2023-12-31 $528,111 50,153
2023-09-30 $482,052 52,741
2023-06-30 $384,866 52,939
2023-03-31 $312,918 36,988
2022-12-31 $772,959 102,924
2022-09-30 $875,687 108,781
2022-06-30 $116,023 10,002
2022-03-31 $136,266 12,145
2021-12-31 $831,672 127,753
2021-09-30 $881,618 115,698
2021-06-30 $1,063,687 84,086